Summary

The patient engagement solutions market is projected to reach USD 51.69 billion by 2030 from USD 29.33 billion in 2025, at a CAGR of 12.0% during the forecast period. Factors such as the rising use of digital solutions that allow real-time communication, personalized interaction, and easy interfacing. Others may include advancements such as cloud solutions, mobile solutions, and analytics. High investment requirements for healthcare infrastructure and a lack of skilled IT professionals in the healthcare sector are anticipated to impede the growth of this market .

https://mnmimg.marketsandmarkets.com/Images/patient-engagement-solutions-market-img-overview.webp

“Services segment is expected to grow at the highest rate during the forecast period.”
By components, the patient engagement solutions market is divided into software, hardware, and services. The services segment is expected to grow at the fastest rate as healthcare organizations increasingly seek support for implementation, customization, integration with EHRs, change management, training, and ongoing optimization of engagement technologies. These professional and managed services help providers and payers maximize the value of engagement platforms, adapt to evolving clinical workflows, and ensure seamless deployment across complex healthcare environments .


“The on-premise segment is anticipated to dominate the Patient Engagement Solutions market in 2024”
By delivery modes, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes. In 2024, the on-premise segment is expected to dominate because many healthcare organizations, especially large hospitals and health systems, prefer to maintain direct control over sensitive patient data and core clinical systems. On-premise deployments also align with established IT infrastructures, existing EHR environments, and stringent security and compliance requirements, making them a dominant choice for organizations prioritizing data governance and internal integration .


“Health management segment accounted for the largest share of the global patient engagement solutions market, by applications”
By application, the patient engagement solutions market is divided into health management, home health management, social and behavioral management, and financial health management. In 2024, the health management applications segment accounts held the largest share of the global patient engagement solutions market. It encompasses comprehensive care coordination, chronic disease management, and population health initiatives that rely heavily on engagement tools to maintain continuous patient communication. These solutions help providers and payers monitor patient outcomes, close care gaps, and support preventive care, making health management the dominant application driving adoption of engagement platforms .

“Providers' segment accounted for the largest share of the global patient engagement solutions market, by end user in 2024.”
By end users, the patient engagement solutions market is divided into providers, payers, patients, and other end users. The providers are further bifurcated into hospitals and healthcare system, ambulatory care centers, home healthcare, and other providers. Moreover the payers is further divided into private and public. By end users, the providers' segment accounted for the largest share of the global patient engagement solutions market in 2024. The large share of this segment is due to increasing implementation of patient engagement solutions to curtail mounting healthcare costs, offer value-based care, and expand financial outcomes are factors that are driving the growth of this segment.

“North America to dominate the patient engagement solutions market
In 2024, North America dominated the global patient engagement solutions market by region. Factors such as favorable government initiatives and regulations, the imperative to reduce healthcare costs, the increasing prevalence of chronic diseases, and the presence of key market players contribute significantly to the growth of the patient engagement solutions market in North America. Strong regulatory frameworks promoting patient access, data interoperability, and value-based care, along with the presence of leading healthcare IT vendors and high healthcare spending, continue to drive market leadership in the region .

Breakdown of supply-side primary interviews, by company type, designation, and region:
? By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
? By Designation: C-level (44%), Director-level (35%), and Others (21%)
? By Region: North America (46%), Europe (26%), Asia Pacific (18%), Latin America (7%), and Middle East & Africa (10%)

McKesson Corporation (US), Veradigm LLC (US), Oracle (US), athenahealth (US), Health Catalyst (US), GetWellNetwork, Inc. (US), Lincata, Inc. (US), Cognizant (US), TruBridge (US), Oneview Healthcare (Ireland), AdvancedMD, Inc. (US), Epic Systems Corporation (US), Harris Healthcare (US), Medical Information Technology, Inc. (US), Tebra Technologies, Inc. (US), Televox (US), Medhost (US), Nuance Communications, Inc. (US) (Microsoft), Solutionreach, Inc. (US), Experian Information Solutions, Inc. (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage
? The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region.
? The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
? The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
? The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total patient engagement solutions market.
? The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report
? This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
? Analysis of key drivers (implementation of government regulations and initiatives to promote patient centric care, increasing adoption of patient engagement solutions, rising number of collaborations and partnerships between stakeholders, increasing utilisation of mobile health apps, rising geriatric population and subsequent increase in prevalence of chronic diseases), restraints (large investment requirement for healthcare infrastructure, protection of patient information, inadequate interoperability across healthcare providers and shortage of skilled IT professionals in the healthcare industry ), opportunities (growth opportunities in emerging markets, wearable health technology, cloud computing solutions), and challenges (high deployment cost of healthcare IT systems, low levels of healthcare literacy) impacting the growth of the patient engagement solutions market.
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.
? Market Development: Comprehensive information on the lucrative emerging markets, component, delivery mode, therapeutic area, application, functionality, end user, and region
? Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient engagement solutions market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global patient engagement market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.3 STUDY SCOPE 42
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 42
1.3.2 INCLUSIONS & EXCLUSIONS 43
1.3.3 YEARS CONSIDERED 44
1.3.4 CURRENCY CONSIDERED 44
1.4 STAKEHOLDERS 45
1.5 SUMMARY OF CHANGES 45
2 EXECUTIVE SUMMARY 47
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 47
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 48
2.3 DISRUPTIVE TRENDS SHAPING MARKET 49
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 50
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 51
3 PREMIUM INSIGHTS 52
3.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW 52
3.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE AND REGION 53
3.3 PATIENT ENGAGEMENT SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT 54
4 MARKET OVERVIEW 55
4.1 INTRODUCTION 55
4.2 MARKET DYNAMICS 55
4.2.1 DRIVERS 56
4.2.1.1 Increasing adoption of telehealth and remote care 56
4.2.1.2 Increasing smartphone use and digital comfort 56
4.2.1.3 Implementation of government regulations and initiatives to promote patient-centric care 57
4.2.1.4 Growing prevalence of chronic diseases and rising demand for long-term patient involvement 57
4.2.2 RESTRAINTS 58
4.2.2.1 Data privacy and cybersecurity concerns 58
4.2.2.2 Inadequate interoperability across healthcare providers 58
4.2.2.3 Shortage of skilled IT professionals in healthcare industry 59
4.2.3 OPPORTUNITIES 59
4.2.3.1 Expansion of remote and home-based care models 59
4.2.3.2 AI-driven personalization in patient engagement solutions 60
4.2.3.3 Integration with wearables and personalized health tech 60
4.2.4 CHALLENGES 60
4.2.4.1 Low patient adoption and engagement over time 60
4.2.4.2 Fragmented data and siloed digital tools 61
4.3 UNMET NEEDS & WHITE SPACES 61
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 61
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 62
5 INDUSTRY TRENDS 63
5.1 PORTER’S FIVE FORCES ANALYSIS 63
5.1.1 BARGAINING POWER OF SUPPLIERS 64
5.1.2 BARGAINING POWER OF BUYERS 64
5.1.3 THREAT OF SUBSTITUTES 64
5.1.4 THREAT OF NEW ENTRANTS 64
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.2 MACROECONOMICS OUTLOOK 65
5.2.1 INTRODUCTION 65
5.2.2 GDP TRENDS AND FORECAST 65
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 65
5.3 VALUE CHAIN ANALYSIS 65
5.4 ECOSYSTEM ANALYSIS 67
5.4.1 ROLE IN ECOSYSTEM 68
5.5 PRICING ANALYSIS 69
5.5.1 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT, 2025 69
5.5.2 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2025 70
5.6 TRADE ANALYSIS 70
5.6.1 IMPORT SCENARIO FOR HS CODE 8528, 2021?2024 71
5.6.2 IMPORT SCENARIO FOR HS CODE 8471, 2021?2024 71
5.6.3 EXPORT SCENARIO FOR HS CODE 8528, 2021?2024 72
5.6.4 EXPORT SCENARIO FOR HS CODE 8471, 2021?2024 73
5.7 KEY CONFERENCES AND EVENTS, 2026?2027 74
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 75
5.9 INVESTMENT & FUNDING SCENARIO 75
5.10 CASE STUDY ANALYSIS 76
5.10.1 ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP 76
5.10.2 BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: CHILDREN’S HOSPITAL CASE STUDY 77
5.10.3 IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT 77
?
5.11 IMPACT OF 2025 US TARIFF ON PATIENT ENGAGEMENT SOLUTIONS MARKET 78
5.11.1 KEY TARIFF RATES 78
5.11.2 PRICE IMPACT ANALYSIS 79
5.11.3 IMPACT ON COUNTRY/REGION 80
5.11.3.1 US 80
5.11.3.2 Europe 80
5.11.3.3 Asia Pacific 80
5.11.4 IMPACT ON END-USE INDUSTRIES 81
5.11.4.1 Hospitals and healthcare systems 81
5.11.4.2 ASCs, ACCs, and other outpatient settings 81
5.11.4.3 Home healthcare providers 81
5.11.4.4 Private payers 81
5.11.4.5 Public payers 81
5.11.4.6 Other end users 81
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 82
6.1 KEY EMERGING TECHNOLOGIES 82
6.1.1 CLOUD COMPUTING 82
6.1.2 API & EHR INTEGRATION TECHNOLOGIES 82
6.1.3 DATA ANALYTICS 82
6.2 COMPLEMENTARY TECHNOLOGIES 83
6.2.1 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 83
6.2.2 CONVERSATIONAL AI/CHATBOTS 83
6.2.3 BEHAVIORAL ANALYTICS AND PERSONALIZATION ENGINES 84
6.3 ADJACENT TECHNOLOGIES 84
6.3.1 CYBERSECURITY AND DATA ENCRYPTION 84
6.3.2 BLOCKCHAIN 85
6.3.3 BIG DATA AND ADVANCED ANALYTICS 85
6.4 TECHNOLOGY/PRODUCT ROADMAP 85
6.5 PATENT ANALYSIS 86
6.5.1 PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTION 86
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 87
6.5.3 LIST OF PATENTS/PATENT APPLICATIONS 88
6.6 FUTURE APPLICATIONS 89
6.6.1 AI-DRIVEN PREDICTIVE ENGAGEMENT 89
6.6.2 CONTINUOUS REMOTE CARE AND HOSPITAL-AT-HOME ENABLEMENT 89
6.6.3 PERSONALIZED DIGITAL THERAPEUTICS AND BEHAVIORAL COACHING 89
6.6.4 CLOSED-LOOP CARE COORDINATION AND VALUE-BASED PERFORMANCE OPTIMIZATION 90
6.6.5 DECENTRALIZED CLINICAL TRIALS AND REAL-WORLD EVIDENCE GENERATION 90
?
6.7 IMPACT OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS MARKET 90
6.7.1 INTRODUCTION 90
6.7.2 MARKET POTENTIAL OF AI/GEN AI IN PATIENT ENGAGEMENT SOLUTIONS MARKET 91
6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 92
6.7.3.1 AI-driven conversational AI for pre/post-op engagement 92
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 93
6.7.4.1 Patient communication & virtual care platforms 93
6.7.4.2 Remote patient monitoring & digital therapeutics 93
6.7.4.3 Population health & health equity programs 94
6.7.5 USER READINESS AND IMPACT ASSESSMENT 94
6.7.5.1 User readiness 94
6.7.5.1.1 User A: Hospitals & clinics 94
6.7.5.1.2 User B: Healthcare providers, employers, and forensic agencies 94
6.7.5.2 Impact assessment 95
6.7.5.2.1 User A: Clinical, reference, and toxicology laboratories 95
6.7.5.2.2 User B: Healthcare providers, employers, and forensic agencies 95
7 REGULATORY LANDSCAPE 96
7.1 REGIONAL REGULATIONS & COMPLIANCE 96
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
7.1.2 REGULATORY FRAMEWORK 101
7.1.2.1 North America 101
7.1.2.2 Europe 102
7.1.2.3 Asia Pacific 102
7.1.2.4 Latin America 103
7.1.2.5 Middle East & Africa 104
7.1.3 INDUSTRY STANDARDS 104
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 105
8.1 INTRODUCTION 105
8.2 DECISION-MAKING PROCESS 105
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 105
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
8.3.2 BUYING CRITERIA 106
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 107
8.5 UNMET NEEDS/END-USER EXPECTATIONS 108
8.5.1 UNMET NEEDS 108
8.5.2 END-USER EXPECTATIONS 109
8.6 MARKET PROFITIBILITY 110
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 111
9.1 INTRODUCTION 112
9.2 HARDWARE 112
9.2.1 IN-ROOM TELEVISIONS 113
9.2.1.1 Rising patient demand for real-time health transparency and smart room modernization initiatives to drive market 113
9.2.2 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES 114
9.2.2.1 Hospitals to increasingly adopt bedside terminals to address workforce shortages and reduce nursing workload 114
9.2.3 TABLETS 115
9.2.3.1 Strong ROI profile, lower upfront investment, and rapid rollout capability to propel market growth 115
9.3 SOFTWARE 116
9.3.1 PRE-CARE ENGAGEMENT 117
9.3.1.1 Increasing adoption of consumer-centric access models to aid segment growth 117
9.3.2 POINT-OF-CARE ENGAGEMENT 118
9.3.2.1 Exponential growth in healthcare data and rising information complexity to augment segment growth 118
9.3.3 POST-CARE ENGAGEMENT 119
9.3.3.1 Shift toward value-based care and reimbursement models for readmission rates to drive segment growth 119
9.4 SERVICES 120
9.4.1 IMPLEMENTATION & INTEGRATION SERVICES 122
9.4.1.1 Need for expertise to operationalize sophisticated patient engagement ecosystems to fuel market growth 122
9.4.2 TRAINING & EDUCATION SERVICES 123
9.4.2.1 Need to eradicate measurable staff usability challenges and patient digital access gaps to drive segment 123
9.4.3 SUPPORT & MAINTENANCE SERVICES 124
9.4.3.1 Dependency on patient portals, telehealth systems, and integrated EHR infrastructures to aid market growth 124
9.4.4 CONSULTING SERVICES 125
9.4.4.1 Shift from volume-based to value-based care models to drive consulting services market 125
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 126
10.1 INTRODUCTION 127
10.2 ON-PREMISES 127
10.2.1 ON-PREMISES ADOPTION TO ACCELERATE AMID SECURITY, REGULATORY, AND INTEGRATION PRIORITIES 127
10.3 CLOUD-BASED 128
10.3.1 CLOUD-BASED PATIENT ENGAGEMENT TO PROPEL SCALABLE, SECURE, AND INTEROPERABLE CARE 128
?
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 130
11.1 INTRODUCTION 131
11.2 CLINICAL CARE 131
11.2.1 VALUE-BASED CARE MODELS AND TELEHEALTH EXPANSION TO PROPEL CLINICAL CARE SEGMENT 131
11.3 CARE COORDINATION & COMMUNICATION 132
11.3.1 FRAGMENTED CARE PATHWAYS AND INTEROPERABILITY MANDATES TO ACCELERATE MARKET GROWTH 132
11.4 HOME & REMOTE CARE 133
11.4.1 HOSPITAL-AT-HOME EXPANSION, READMISSION PENALTIES, AND RPM REIMBURSEMENT TO FUEL SEGMENT GROWTH 133
11.5 POPULATION HEALTH & BEHAVIORAL ENGAGEMENT 135
11.5.1 VALUE-BASED CARE MANDATES, RISK STRATIFICATION, AND BEHAVIORAL HEALTH INTEGRATION TO PROPEL SEGMENT GROWTH 135
11.6 FINANCIAL ENGAGEMENT 136
11.6.1 RISING OUT-OF-POCKET COSTS, CONSUMERISM, AND REVENUE PRESSURE TO DRIVE FINANCIAL ENGAGEMENT ADOPTION 136
11.7 OTHER APPLICATIONS 137
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 139
12.1 INTRODUCTION 140
12.2 CHRONIC DISEASES 140
12.2.1 CARDIOVASCULAR DISEASES 142
12.2.1.1 Need for continuous monitoring and preventive engagement through digital health platforms to drive market 142
12.2.2 DIABETES 143
12.2.2.1 Continuous glucose monitoring, behavioral adherence, and data-driven self-management through digital engagement to drive market 143
12.2.3 OBESITY 144
12.2.3.1 Preventive engagement, behavioral modification, and long-term risk reduction through digital health platforms to drive market 144
12.2.4 RESPIRATORY DISORDERS 145
12.2.4.1 Advancing continuous symptom monitoring and preventive care through digital engagement platforms to fuel market growth 145
12.2.5 ONCOLOGY 146
12.2.5.1 Longitudinal care coordination, symptom monitoring, and survivorship engagement to boost market 146
12.2.6 OTHER CHRONIC DISEASES 146
12.3 WOMEN'S HEALTH 147
12.3.1 PREVENTIVE SCREENING, REPRODUCTIVE CARE COORDINATION, AND LIFECYCLE ENGAGEMENT TO AID MARKET GROWTH 147
12.4 BEHAVIORAL & MENTAL HEALTH 148
12.4.1 INCREASING GLOBAL PREVALENCE OF DEPRESSION, ANXIETY, SUBSTANCE USE DISORDERS TO AID MARKET GROWTH 148
12.5 OTHER THERAPEUTIC AREAS 149
13 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY 151
13.1 INTRODUCTION 152
13.2 PATIENT/CLIENT SCHEDULING 152
13.2.1 DIGITAL-FIRST, MOBILE-DRIVEN SCHEDULING TO REDUCE NO-SHOWS AND STRENGTHEN ACCESS PERFORMANCE 152
13.3 TELEHEALTH 153
13.3.1 TELEHEALTH TO DRIVE QUALITY IMPROVEMENT AND HYBRID CARE DELIVERY GROWTH 153
13.4 E-PRESCRIBING 154
13.4.1 E-PRESCRIBING TO STRENGTHEN MEDICATION SAFETY REGULATORY COMPLIANCE 154
13.5 DOCUMENT MANAGEMENT 155
13.5.1 DIGITAL RECORD ACCESS TO DRIVE DOCUMENT MANAGEMENT IN CORE PATIENT ENGAGEMENT INFRASTRUCTURE 155
13.6 BILLING & PAYMENTS 157
13.6.1 RISING PATIENT FINANCIAL RESPONSIBILITY AND GROWING DEMAND FOR DIGITAL TRANSPARENCY TO DRIVE MARKET 157
13.7 PATIENT EDUCATION 158
13.7.1 SELF-DIRECTED HEALTH RESEARCH AND DIGITAL LITERACY GAPS TO RISE DEMAND FOR INTEGRATED PATIENT EDUCATION TOOLS 158
13.8 OTHER FUNCTIONALITIES 159
14 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 160
14.1 INTRODUCTION 161
14.2 PROVIDERS 161
14.2.1 HOSPITALS & HEALTHCARE SYSTEMS 162
14.2.1.1 Healthcare systems to drive patient experience and operational efficiency through integrated patient engagement solutions 162
14.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS 163
14.2.2.1 Need for optimizing patient access and engagement in outpatient care settings to propel segment growth 163
14.2.3 HOME HEALTHCARE PROVIDERS 164
14.2.3.1 Home healthcare provides to enhance patient engagement and remote care delivery in home settings 164
14.2.4 OTHER PROVIDERS 164
14.3 PAYERS 165
14.3.1 PRIVATE PAYERS 166
14.3.1.1 Private payers to enhance member experience and cost efficiency through digital-first engagement strategies 166
14.3.2 PUBLIC PAYERS 167
14.3.2.1 Public payers to strengthen population health management through inclusive and scalable digital engagement 167
14.4 OTHER END USERS 168
?
15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 169
15.1 INTRODUCTION 170
15.2 NORTH AMERICA 170
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
15.2.2 US 178
15.2.2.1 Value-based care reforms and long-term care management need to accelerate market growth 178
15.2.3 CANADA 183
15.2.3.1 Government policies to strengthen digital health infrastructure and interoperability 183
15.3 EUROPE 188
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 188
15.3.2 GERMANY 194
15.3.2.1 Nationwide ePA rollout and digital therapeutics leadership to propel market growth 194
15.3.3 FRANCE 200
15.3.3.1 Near-universal digital health record adoption and strategic investment to aid market growth 200
15.3.4 UK 205
15.3.4.1 NHS app scale-up and virtual care expansion to boost market growth 205
15.3.5 ITALY 210
15.3.5.1 Rising digital health investment and growing focus on national telemedicine infrastructure to fuel market growth 210
15.3.6 SPAIN 215
15.3.6.1 Rising telemedicine expansion and growing mHealth adoption to strengthen market 215
15.3.7 REST OF EUROPE 220
15.4 ASIA PACIFIC 226
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 226
15.4.2 CHINA 233
15.4.2.1 High digital health adoption and internet hospital expansion to accelerate market growth 233
15.4.3 JAPAN 238
15.4.3.1 Healthcare digitalization to accelerate patient engagement in Japan 238
15.4.4 INDIA 243
15.4.4.1 Digital public health infrastructure and mobile penetration to augment market growth 243
15.4.5 SOUTH KOREA 248
15.4.5.1 National digital integration and rapid population aging to aid market growth 248
15.4.6 AUSTRALIA 253
15.4.6.1 Near-universal digital records and embedded telehealth adoption to fuel market growth 253
15.4.7 REST OF ASIA PACIFIC 258
?
15.5 LATIN AMERICA 264
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 264
15.5.2 BRAZIL 270
15.5.2.1 Government-led telehealth scale and institutionalized patient participation to propel digital engagement 270
15.5.3 MEXICO 275
15.5.3.1 Structural health system gaps to spur digital patient engagement adoption 275
15.5.4 REST OF LATIN AMERICA 280
15.6 MIDDLE EAST & AFRICA 285
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 285
15.6.2 GCC COUNTRIES 290
15.6.2.1 High NCD burden and government-owned digital platforms to augment patient engagement 290
15.6.2.2 Kingdom of Saudi Arabia 295
15.6.2.2.1 Government-led digital health innovations to accelerate patient engagement 295
15.6.2.3 UAE 300
15.6.2.3.1 Progressive digital health innovations to strengthen UAE patient engagement solutions market 300
15.6.2.4 Rest of GCC countries 304
15.6.3 SOUTH AFRICA 309
15.6.3.1 Massive telemedicine adoption and innovative digital platforms to aid market growth 309
15.6.4 REST OF MIDDLE EAST & AFRICA 314
16 COMPETITIVE LANDSCAPE 320
16.1 INTRODUCTION 320
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 320
16.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 320
16.3 REVENUE ANALYSIS, 2020?2024 322
16.4 MARKET SHARE ANALYSIS, 2024 323
16.5 BRAND COMPARISON 325
16.6 COMPANY VALUATION & FINANCIAL METRICS 326
16.6.1 FINANCIAL METRICS 326
16.6.2 COMPANY VALUATION 326
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 327
16.7.1 STARS 327
16.7.2 EMERGING LEADERS 327
16.7.3 PERVASIVE PLAYERS 327
16.7.4 PARTICIPANTS 327
?
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 329
16.7.5.1 Company footprint 329
16.7.5.2 Region footprint 330
16.7.5.3 Component footprint 331
16.7.5.4 Application footprint 332
16.7.5.5 End-user footprint 333
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 333
16.8.1 PROGRESSIVE COMPANIES 333
16.8.2 RESPONSIVE COMPANIES 334
16.8.3 DYNAMIC COMPANIES 334
16.8.4 STARTING BLOCKS 334
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 335
16.8.5.1 Detailed list of key startups/SMEs 335
16.8.5.2 Competitive benchmarking of startups/SMEs 335
16.9 COMPETITIVE SCENARIO 336
16.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 336
16.9.2 DEALS 337
16.9.3 EXPANSIONS 338
16.9.4 OTHER DEVELOPMENTS 338
17 COMPANY PROFILES 339
17.1 KEY PLAYERS 339
17.1.1 MCKESSON CORPORATION 339
17.1.1.1 Business overview 339
17.1.1.2 Products offered 340
17.1.1.3 Recent developments 341
17.1.1.3.1 Deals 341
17.1.1.4 MnM view 341
17.1.1.4.1 Right to win 341
17.1.1.4.2 Strategic choices 342
17.1.1.4.3 Weaknesses & competitive threats 342
17.1.2 ORACLE 343
17.1.2.1 Business overview 343
17.1.2.2 Products offered 344
17.1.2.3 Recent developments 345
17.1.2.3.1 Product launches 345
17.1.2.3.2 Deals 345
17.1.2.4 MnM view 346
17.1.2.4.1 Right to win 346
17.1.2.4.2 Strategic choices 346
17.1.2.4.3 Weaknesses & competitive threats 346
?
17.1.3 MICROSOFT (NUANCE COMMUNICATIONS, INC.) 347
17.1.3.1 Business overview 347
17.1.3.2 Products offered 348
17.1.3.3 Recent developments 349
17.1.3.3.1 Product launches 349
17.1.3.3.2 Deals 349
17.1.3.4 MnM view 349
17.1.3.4.1 Right to win 349
17.1.3.4.2 Strategic choices 350
17.1.3.4.3 Weaknesses & competitive threats 350
17.1.4 TRUBRIDGE 351
17.1.4.1 Business overview 351
17.1.4.2 Products offered 352
17.1.4.3 Recent developments 353
17.1.4.3.1 Deals 353
17.1.4.4 MnM view 354
17.1.4.4.1 Right to win 354
17.1.4.4.2 Strategic choices 354
17.1.4.4.3 Weaknesses & competitive threats 354
17.1.5 HEALTH CATALYST 355
17.1.5.1 Business overview 355
17.1.5.2 Products offered 356
17.1.5.3 Recent developments 357
17.1.5.3.1 Deals 357
17.1.5.4 MnM view 357
17.1.5.4.1 Right to win 357
17.1.5.4.2 Strategic choices 357
17.1.5.4.3 Weaknesses & competitive threats 357
17.1.6 VERADIGM LLC 358
17.1.6.1 Business overview 358
17.1.6.2 Products offered 359
17.1.6.3 Recent developments 360
17.1.6.3.1 Product launches 360
17.1.6.3.2 Deals 360
17.1.7 ATHENAHEALTH 361
17.1.7.1 Business overview 361
17.1.7.2 Products offered 361
17.1.7.3 Recent developments 362
17.1.7.3.1 Product launches and enhancements 362
17.1.7.3.2 Deals 363
17.1.7.3.3 Other developments 363
?
17.1.8 GETWELLNETWORK, INC. 365
17.1.8.1 Business overview 365
17.1.8.2 Products offered 365
17.1.8.3 Recent developments 366
17.1.8.3.1 Product enhancements 366
17.1.8.3.2 Deals 367
17.1.9 LINCATA, INC. 368
17.1.9.1 Business overview 368
17.1.9.2 Products offered 368
17.1.10 COGNIZANT 370
17.1.10.1 Business overview 370
17.1.10.2 Products offered 371
17.1.10.3 Recent developments 372
17.1.10.3.1 Deals 372
17.1.11 ONEVIEW HEALTHCARE 373
17.1.11.1 Business overview 373
17.1.11.2 Products offered 374
17.1.11.3 Recent developments 375
17.1.11.3.1 Product launches and enhancements 375
17.1.11.3.2 Deals 376
17.1.11.3.3 Other developments 376
17.1.12 ADVANCEDMD, INC. 377
17.1.12.1 Business overview 377
17.1.12.2 Products offered 377
17.1.12.3 Recent developments 379
17.1.12.3.1 Product enhancements 379
17.1.12.3.2 Deals 380
17.1.13 EPIC SYSTEMS CORPORATION 381
17.1.13.1 Business overview 381
17.1.13.2 Products offered 381
17.1.13.3 Recent developments 382
17.1.13.3.1 Product enhancement 382
17.1.13.3.2 Deals 383
17.1.14 HARRIS HEALTHCARE 384
17.1.14.1 Business overview 384
17.1.14.2 Products offered 384
17.1.14.3 Recent developments 385
17.1.14.3.1 Deals 385
?
17.1.15 MEDICAL INFORMATION TECHNOLOGY, INC. 386
17.1.15.1 Business overview 386
17.1.15.2 Products offered 386
17.1.15.3 Recent developments 387
17.1.15.3.1 Deals 387
17.1.15.3.2 Other developments 387
17.1.16 TEBRA TECHNOLOGIES, INC. 388
17.1.16.1 Business overview 388
17.1.16.2 Products offered 388
17.1.16.3 Recent developments 389
17.1.16.3.1 Product enhancements 389
17.1.16.3.2 Deals 389
17.1.17 TELEVOX 390
17.1.17.1 Business overview 390
17.1.17.2 Products offered 390
17.1.17.3 Recent developments 391
17.1.17.3.1 Product launches 391
17.1.17.3.2 Deals 391
17.1.18 SOLUTIONREACH, INC. 392
17.1.18.1 Business overview 392
17.1.18.2 Products offered 392
17.1.18.3 Recent developments 393
17.1.18.3.1 Product launches and enhancements 393
17.1.19 EXPERIAN INFORMATION SOLUTIONS, INC. 394
17.1.19.1 Business overview 394
17.1.19.2 Products offered 395
17.1.20 ECLINICALWORKS 397
17.1.20.1 Business overview 397
17.1.20.2 Products offered 397
17.2 OTHER PLAYERS 398
17.2.1 WELLSTACK 398
17.2.2 RELATIENT 399
17.2.3 LUMA HEALTH INC. 400
17.2.4 CIPHERHEALTH INC. 401
17.2.5 YOSI HEALTH 402
?
18 RESEARCH METHODOLOGY 403
18.1 RESEARCH APPROACH 403
18.1.1 SECONDARY RESEARCH 403
18.1.1.1 Key secondary sources 404
18.1.1.2 Key data from secondary sources 405
18.1.2 PRIMARY RESEARCH 405
18.1.2.1 Primary sources 406
18.1.2.2 Key objectives of primary research 406
18.1.2.3 Key data from primary sources 407
18.1.2.4 Breakdown of primaries 407
18.1.2.5 Insights from primary experts 408
18.2 RESEARCH METHODOLOGY DESIGN 408
18.3 MARKET SIZE ESTIMATION 409
18.3.1 BOTTOM-UP APPROACH (REVENUE SHARE ANALYSIS) 409
18.3.2 TOP-DOWN OF PARENT MARKET ASSESSMENT 410
18.3.3 PRIMARY INTERVIEWS 410
18.3.4 TOP-DOWN APPROACH 410
18.4 DATA TRIANGULATION 415
18.5 MARKET SHARE ESTIMATION 415
18.6 STUDY ASSUMPTIONS 416
18.7 RESEARCH LIMITATIONS 416
18.8 RISK ANALYSIS 417
19 APPENDIX 418
19.1 DISCUSSION GUIDE 418
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 422
19.3 CUSTOMIZATION OPTIONS 424
19.4 RELATED REPORTS 424
19.5 AUTHOR DETAILS 425

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS 43
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 44
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON PATIENT ENGAGEMENT SOLUTIONS MARKET 63
TABLE 4 ROLE OF COMPANIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET ECOSYSTEM 68
TABLE 5 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT,
2025 (USD) 69
TABLE 6 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION,
2025 (USD) 70
TABLE 7 IMPORT SCENARIO FOR HS CODE 8528, 2021?2024 (USD THOUSAND) 71
TABLE 8 IMPORT SCENARIO FOR HS CODE 8741, 2021?2024 (USD THOUSAND) 71
TABLE 9 EXPORT SCENARIO FOR HS CODE 8528, 2021?2024 (USD THOUSAND) 72
TABLE 10 EXPORT SCENARIO FOR HS CODE 8471, 2021?2024 (USD THOUSAND) 73
TABLE 11 LIST OF KEY CONFERENCES AND EVENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2026?DECEMBER 2027 74
TABLE 12 CASE STUDY 1: ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP 76
TABLE 13 CASE STUDY 2: BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: A CHILDREN’S HOSPITAL CASE STUDY 77
TABLE 14 CASE STUDY 3: IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT 77
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 78
TABLE 16 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT ENGAGEMENT SOLUTIONS MARKET 87
TABLE 17 LIST OF PATENTS/PATENT APPLICATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 88
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 23 REGULATORY SCENARIO OF NORTH AMERICA 101
TABLE 24 REGULATORY SCENARIO OF EUROPE 102
TABLE 25 REGULATORY SCENARIO OF ASIA PACIFIC 102
TABLE 26 REGULATORY SCENARIO OF LATIN AMERICA 103
TABLE 27 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 104
TABLE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF MAJOR
END USERS (%) 106
TABLE 29 KEY BUYING CRITERIA FOR TOP THREE END USERS 107
TABLE 30 UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 108
TABLE 31 END-USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 109
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 112
TABLE 33 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT HARDWARE MARKET 112
TABLE 34 PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 113
TABLE 35 PATIENT ENGAGEMENT HARDWARE MARKET, BY REGION,
2024?2031 (USD MILLION) 113
TABLE 36 PATIENT ENGAGEMENT HARDWARE MARKET FOR IN-ROOM TELEVISIONS,
BY REGION, 2024?2031 (USD MILLION) 114
TABLE 37 PATIENT ENGAGEMENT HARDWARE MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY REGION, 2024?2031 (USD MILLION) 115
TABLE 38 PATIENT ENGAGEMENT HARDWARE MARKET FOR TABLETS, BY REGION,
2024?2031 (USD MILLION) 116
TABLE 39 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOFTWARE MARKET 116
TABLE 40 PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 117
TABLE 41 PATIENT ENGAGEMENT SOFTWARE MARKET, BY REGION,
2024?2031 (USD MILLION) 117
TABLE 42 PATIENT ENGAGEMENT SOFTWARE MARKET FOR PRE-CARE ENGAGEMENT,
BY REGION, 2024?2031 (USD MILLION) 118
TABLE 43 PATIENT ENGAGEMENT SOFTWARE MARKET FOR POINT-OF-CARE ENGAGEMENT, BY REGION, 2024?2031 (USD MILLION) 119
TABLE 44 PATIENT ENGAGEMENT SOFTWARE MARKET FOR POST-CARE ENGAGEMENT,
BY REGION, 2024?2031 (USD MILLION) 120
TABLE 45 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SERVICES MARKET 121
TABLE 46 PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 121
TABLE 47 PATIENT ENGAGEMENT SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 121
TABLE 48 PATIENT ENGAGEMENT SERVICES MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024?2031 (USD MILLION) 122
TABLE 49 PATIENT ENGAGEMENT SERVICES MARKET FOR TRAINING & EDUCATION SERVICES, BY REGION, 2024?2031 (USD MILLION) 123
TABLE 50 PATIENT ENGAGEMENT SERVICES MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024?2031 (USD MILLION) 124
TABLE 51 PATIENT ENGAGEMENT SERVICES MARKET FOR CONSULTING SERVICES,
BY REGION, 2024?2031 (USD MILLION) 125
TABLE 52 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 127
TABLE 53 KEY COMPANIES OFFERING ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS 127
TABLE 54 ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2024?2031 (USD MILLION) 128
TABLE 55 KEY COMPANIES OFFERING CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS 128
TABLE 56 CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2024?2031 (USD MILLION) 129
TABLE 57 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 131
TABLE 58 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS
FOR CLINICAL CARE 132
TABLE 59 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICAL CARE, BY REGION, 2024?2031 (USD MILLION) 132
TABLE 60 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CARE COORDINATION & COMMUNICATION 133
TABLE 61 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARE COORDINATION & COMMUNICATION, BY REGION, 2024?2031 (USD MILLION) 133
TABLE 62 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR HOME & REMOTE CARE 134
TABLE 63 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME & REMOTE CARE,
BY REGION, 2024?2031 (USD MILLION) 134
TABLE 64 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT 135
TABLE 65 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT, BY REGION, 2024?2031 (USD MILLION) 136
TABLE 66 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL ENGAGEMENT 137
TABLE 67 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL ENGAGEMENT,
BY REGION, 2024?2031 (USD MILLION) 137
TABLE 68 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER APPLICATIONS 137
TABLE 69 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER APPLICATIONS,
BY REGION, 2024?2031 (USD MILLION) 138
TABLE 70 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2024?2031 (USD MILLION) 140
TABLE 71 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CHRONIC DISEASES 141
TABLE 72 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 141
TABLE 73 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2024?2031 (USD MILLION) 141
TABLE 74 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2024?2031 (USD MILLION) 143
TABLE 75 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION,
2024?2031 (USD MILLION) 144
TABLE 76 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION,
2024?2031 (USD MILLION) 144
TABLE 77 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR RESPIRATORY DISORDERS,
BY REGION, 2024?2031 (USD MILLION) 145
TABLE 78 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ONCOLOGY, BY REGION,
2024?2031 (USD MILLION) 146
TABLE 79 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES,
BY REGION, 2024?2031 (USD MILLION) 147
TABLE 80 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR WOMEN’S HEALTH 148
TABLE 81 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2024?2031 (USD MILLION) 148
TABLE 82 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BEHAVIORAL & MENTAL HEALTH 149
TABLE 83 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BEHAVIORAL & MENTAL HEALTH, BY REGION, 2024?2031 (USD MILLION) 149
TABLE 84 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER THERAPEUTIC AREAS 150
TABLE 85 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS,
BY REGION, 2024?2031 (USD MILLION) 150
TABLE 86 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 152
TABLE 87 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT/CLIENT SCHEDULING 153
TABLE 88 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2024?2031 (USD MILLION) 153
TABLE 89 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR TELEHEALTH 154
TABLE 90 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2024?2031 (USD MILLION) 154
TABLE 91 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR E-PRESCRIBING 155
TABLE 92 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2024?2031 (USD MILLION) 155
TABLE 93 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR DOCUMENT MANAGEMENT 156
TABLE 94 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT,
BY REGION, 2024?2031 (USD MILLION) 156
TABLE 95 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BILLING & PAYMENTS 157
TABLE 96 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS,
BY REGION, 2024?2031 (USD MILLION) 157
TABLE 97 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT EDUCATION 158
TABLE 98 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION,
BY REGION, 2024?2031 (USD MILLION) 158
TABLE 99 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER FUNCTIONALITIES 159
TABLE 100 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES,
BY REGION, 2024?2031 (USD MILLION) 159
TABLE 101 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 161
TABLE 102 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS 161
TABLE 103 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE,
2024?2031 (USD MILLION) 162
TABLE 104 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION,
2024?2031 (USD MILLION) 162
TABLE 105 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024?2031 (USD MILLION) 163
TABLE 106 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024?2031 (USD MILLION) 163
TABLE 107 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTHCARE PROVIDERS, BY REGION, 2024?2031 (USD MILLION) 164
TABLE 108 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2024?2031 (USD MILLION) 165
TABLE 109 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS 165
TABLE 110 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE,
2024?2031 (USD MILLION) 166
TABLE 111 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION,
2024?2031 (USD MILLION) 166
TABLE 112 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2024?2031 (USD MILLION) 167
TABLE 113 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2024?2031 (USD MILLION) 167
TABLE 114 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO OTHER END USERS 168
TABLE 115 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2024?2031 (USD MILLION) 168
TABLE 116 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2024?2031 (USD MILLION) 170
TABLE 117 NORTH AMERICA: KEY MACROINDICATORS 172
TABLE 118 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 173
TABLE 119 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 173
TABLE 120 NORTH AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 173
TABLE 121 NORTH AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 122 NORTH AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 123 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 174
TABLE 124 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 175
TABLE 125 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 175
TABLE 126 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 176
TABLE 127 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 176
TABLE 128 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024?2031 (USD MILLION) 177
TABLE 129 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 130 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS,
BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 131 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 178
TABLE 132 US: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 179
TABLE 133 US: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 179
TABLE 134 US: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 179
TABLE 135 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 180
TABLE 136 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 180
TABLE 137 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2024?2031 (USD MILLION) 180
TABLE 138 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 181
TABLE 139 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 181
TABLE 140 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 182
TABLE 141 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 182
TABLE 142 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE,
2024?2031 (USD MILLION) 182
TABLE 143 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 183
TABLE 144 CANADA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 183
TABLE 145 CANADA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 184
TABLE 146 CANADA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 184
TABLE 147 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 184
TABLE 148 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 185
TABLE 149 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 185
TABLE 150 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 186
TABLE 151 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 186
TABLE 152 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 187
TABLE 153 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 187
TABLE 154 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 187
TABLE 155 EUROPE: KEY MACROINDICATORS 189
TABLE 156 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 189
TABLE 157 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 190
TABLE 158 EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 190
TABLE 159 EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 190
TABLE 160 EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 191
TABLE 161 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 191
TABLE 162 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 191
TABLE 163 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 192
TABLE 164 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 192
TABLE 165 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 193
TABLE 166 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 193
TABLE 167 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 194
TABLE 168 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 194
TABLE 169 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 195
TABLE 170 GERMANY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 171 GERMANY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 196
TABLE 172 GERMANY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 196
TABLE 173 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 196
TABLE 174 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 197
TABLE 175 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 197
TABLE 176 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 198
TABLE 177 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 198
TABLE 178 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 199
TABLE 179 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 199
TABLE 180 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 199
TABLE 181 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 200
TABLE 182 FRANCE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 201
TABLE 183 FRANCE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 201
TABLE 184 FRANCE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 201
TABLE 185 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 202
TABLE 186 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 202
TABLE 187 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 202
TABLE 188 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 203
TABLE 189 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 203
TABLE 190 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 204
TABLE 191 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 192 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 193 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 205
TABLE 194 UK: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 206
TABLE 195 UK: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 206
TABLE 196 UK: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 206
TABLE 197 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 207
TABLE 198 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 207
TABLE 199 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2024?2031 (USD MILLION) 207
TABLE 200 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 208
TABLE 201 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 208
TABLE 202 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 209
TABLE 203 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 209
TABLE 204 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE,
2024?2031 (USD MILLION) 209
TABLE 205 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 211
TABLE 206 ITALY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 211
TABLE 207 ITALY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 211
TABLE 208 ITALY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 212
TABLE 209 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 212
TABLE 210 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 212
TABLE 211 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 213
TABLE 212 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 213
TABLE 213 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 214
TABLE 214 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 214
TABLE 215 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 215
TABLE 216 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE,
2024?2031 (USD MILLION) 215
TABLE 217 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 216
TABLE 218 SPAIN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 216
TABLE 219 SPAIN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 216
TABLE 220 SPAIN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 217
TABLE 221 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 217
TABLE 222 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 217
TABLE 223 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 218
TABLE 224 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 218
TABLE 225 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 219
TABLE 226 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 219
TABLE 227 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 228 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 229 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 221
TABLE 230 REST OF EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 221
TABLE 231 REST OF EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 222
TABLE 232 REST OF EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 222
TABLE 233 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 222
TABLE 234 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 223
TABLE 235 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 223
TABLE 236 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 237 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY FUNCTIONALITY, 2024?2031 (USD MILLION) 224
TABLE 238 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024?2031 (USD MILLION) 225
TABLE 239 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 225
TABLE 240 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS,
BY TYPE, 2024?2031 (USD MILLION) 225
TABLE 241 ASIA PACIFIC: KEY MACROINDICATORS 227
TABLE 242 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 228
TABLE 243 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 228
TABLE 244 ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 228
TABLE 245 ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 229
TABLE 246 ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 229
TABLE 247 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 229
TABLE 248 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 230
TABLE 249 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 230
TABLE 250 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 231
TABLE 251 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 231
TABLE 252 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 232
TABLE 253 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 232
TABLE 254 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 232
TABLE 255 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 233
TABLE 256 CHINA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 233
TABLE 257 CHINA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 234
TABLE 258 CHINA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 234
TABLE 259 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 234
TABLE 260 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 235
TABLE 261 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 235
TABLE 262 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 236
TABLE 263 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 236
TABLE 264 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 237
TABLE 265 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 237
TABLE 266 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 237
TABLE 267 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 238
TABLE 268 JAPAN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 238
TABLE 269 JAPAN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 270 JAPAN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 271 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 239
TABLE 272 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 240
TABLE 273 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 240
TABLE 274 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 241
TABLE 275 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 241
TABLE 276 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 242
TABLE 277 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 278 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 242TABLE 279 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 243
TABLE 280 INDIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 244
TABLE 281 INDIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 244
TABLE 282 INDIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 244
TABLE 283 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2024?2031 (USD MILLION) 245
TABLE 284 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 245
TABLE 285 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 245
TABLE 286 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 287 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2024?2031 (USD MILLION) 246
TABLE 288 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 247
TABLE 289 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 247
TABLE 290 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE,
2024?2031 (USD MILLION) 247
TABLE 291 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 248
TABLE 292 SOUTH KOREA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 249
TABLE 293 SOUTH KOREA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 249
TABLE 294 SOUTH KOREA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 249
TABLE 295 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 250
TABLE 296 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 250
TABLE 297 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 250
TABLE 298 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 251
TABLE 299 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 251
TABLE 300 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024?2031 (USD MILLION) 252
TABLE 301 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 252
TABLE 302 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS,
BY TYPE, 2024?2031 (USD MILLION) 252
TABLE 303 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 254
TABLE 304 AUSTRALIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 254
TABLE 305 AUSTRALIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 254
TABLE 306 AUSTRALIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE,
2024?2031 (USD MILLION) 255
TABLE 307 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 255
TABLE 308 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 255
TABLE 309 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 256
TABLE 310 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 256
TABLE 311 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024?2031 (USD MILLION) 257
TABLE 312 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2024?2031 (USD MILLION) 257
TABLE 313 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 258
TABLE 314 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 258
TABLE 315 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 259
TABLE 316 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 259
TABLE 317 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 260
TABLE 318 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024?2031 (USD MILLION) 260
TABLE 319 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024?2031 (USD MILLION) 260
TABLE 320 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 261
TABLE 321 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2024?2031 (USD MILLION) 261
TABLE 322 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024?2031 (USD MILLION) 262
TABLE 323 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY FUNCTIONALITY, 2024?2031 (USD MILLION) 262
TABLE 324 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024?2031 (USD MILLION) 263
TABLE 325 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 263
TABLE 326 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024?2031 (USD MILLION) 263
TABLE 327 LATIN AMERICA: KEY MACROINDICATORS 265
TABLE 328 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 265
TABLE 329 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 265
TABLE 330 LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 266
TABLE 331 LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET